INTRODUCTION
Orofacial pain encompasses diseases represented by temporomandibular disorders (TMD), headache and other conditions, which reduce patients' quality of life and involve billions of dol-lars in health care annually 1, 2 . TMD are musculoskeletal disorders, affecting temporomandibular joint (TMJ), masticatory muscles and associated structures 3 . Among the TMDs, myofascial pain (MFP) stands out, which singly corresponds to 45.3% of the diagnoses 4 . It is defined as regional muscle pain associated with palpation sensitivity, characterized by the presence of hypersensitive points of muscle tissue (trigger points) 1, 3, 5 . MFPpatients are significantly more likely to depression and anxiety when compared to patients with joint dysfunction 6 . About 55% of MFP-patients report migraine episodes 7 . Migraine is defined as a primary headache, with 4 to 72 hours attacks, and characterized by unilateral pulsatile pain of moderate to intense intensity, aggravated by routine physical activity, associated with combinations of nausea, vomiting, photophobia, phonophobia, and aura 8 . Migraine-patients are more likely to have depression (2.2 to 4.0 times) and anxiety disorders (3.5 to 5.3 times) 9 . Although MFP and migraine present distinct pathophysiologies, the masticatory muscles receive trigeminal sensory innervation, which is also responsible for the nociceptive impulses conduction of the cranial blood vessels involved in the migraine genesis, allowing a possible overlap of nociceptive stimuli in cases of comorbidities 10 . TMD-patients experience increased headache frequency and severity in addition to a 10-fold higher migraine prevalence 11 . Although it is reported that the concomitant occurrence of MFP and migraine leads to higher levels of pain at palpation, subjective pain perception and sleep/rest problems 12 , studies investigating the psychological and emotional conditions in these cases are still scarce. This knowledge can contribute to the understanding of these conditions. This study aimed to compare the anxiety, depression and disability indexes in MFP-patients, with and without an additional migraine diagnosis.
METHODS
A cross-sectional observational analytical study was carried out, following the recommendations of the Strengthening the Reporting of Observational Studies in Epidemiology (Strobe) 13 14 , composed of 21 items, was used to assess the anxiety level. Patients were told to indicate, among the symptoms described, how often they were perceived during the last week, including the evaluation day. The answer sheet contained four grades: absolutely not, slightly, moderately, and severely, which actually constitute a scalar series, from zero to 3 points. The sum of the individual scores represents the total score, which could range from zero to 63. After this sum, a conversion table, standardized by the inventory, classified the anxiety level into mild (zero-21 points) moderate (22-35 points) and severe (36-63 points). The depressive state was analyzed according to the Beck's Depression Inventory (BDI) 15 , composed of a 21-items questionnaire with graded affirmations from zero to 3, reflecting the symptom's intensity. The maximum score is 63, denoting the highest level of depression. Depression levels were classified as: absent (zero-9 points), mild to moderate (10-18 points), moderate to severe (19-29 points) and severe (30-63 points). In order to assess headache-related disability, patients were invited to answer the Migraine Disability Assessment Questionnaire (MIDAS) 16 . This questionnaire presents 7 questions, the first 5 of which determine the final score and are based on 3 activity spheres. Questions 1, 3, and 5 evaluate the number of days lost due to headache pain at school or work, homework, and social, family, and leisure activities in the last three months. Questions 2 and 4 evaluate the number of additional days, with a significant decrease in the activity (at least 50% reduction in productivity), either in paid or domestic work, in the last three months. Still, two additional questions assess the attacks frequency and the pain intensity. As these last two do not contribute to the final score, they were not included in the questionnaire in the present study. The sum of the days, reported in the first 5 test questions, ranks the individual in one of the following 4 disability degrees: absence (I: zero-5 points), mild (II: 6-10 points), moderate (III: 11-20 points) and severe (IV: >21 points). All Inventories were used in their official English version, following their specific recommendations. The application and interpretation of these tests were done by a responsible psychologist, pain psychology specialist. The present study was approved by UCLA's Ethics Committee on 07/27/2005. pain, with and without the additional diagnosis of migraine Rev Dor. São Paulo, 2017 jul-sep;18(3):189-93
Statistical analysis
In order to detect possible differences between groups 1 and 2 in relation to BAI, BDI, and MIDAS, the non-parametric MannWhitney test was used at a significance level of 5%. All analysis in this study were performed using SPSS software version 13.0.
RESULTS
The sample consisted of 203 patients, with 181 women (89.2%) and 22 men (10.8%), with an average age of 40.3±15.44 years. Group 1 was composed of 120 patients (59.11%), and group 2 was composed of 83 patients (40.89%). Regarding the BAI and BDI levels, the averages obtained comprised both groups in the mild anxiety score and in the mild to moderate depression score. In addition, group 2 presented values statistically higher than those of group 1 (p<0.05) in both questionnaires. Table 1 presents the descriptive measures and the comparison between groups of anxiety and depression levels. The MIDAS questionnaire's results analysis showed that group 2 presented a greater number of lost and/or impaired days in relation to group 1 in all questions, with statistical significance in the first 4 (p<0.05) ( Table 2 ). The total number of lost and/or impaired days was also statistically higher in group 2 (p <0.05). Group 2 patients lost or had their production impaired in 56.40 days and the group 1 in 35.33 days. The patients' percentage distribution in relation to the final score obtained by the MIDAS questionnaire, in each group, are shown in table 3. Absent or mild levels of disability were higher in group 1, while moderate and severe levels were higher in group 2. 
DISCUSSION
Pain is an individual experience of high complexity, involving different aspects of life 1 . Comparing the anxiety, depression and disability indexes, MFP-patients with an additional diagnosis of migraine presented significantly higher indexes (p<0.05) than patients with only MFP, supporting the null hypothesis rejection. The sample consisted of 203 patients, with a woman:man ratio of 8.2:1. This proportion is expected since women seek for TMD-treatment seven times more than men 3 . This result is also close to that found by Zebenholzer et al. 17 , who in their multicenter study on the depression and anxiety impact on the burden and management of episodic and chronic headaches, had their sample composed of 84.1% of women in the episodic headache's group, and 79.1% in the chronic headache's group. Still, in relation to the sample, 59.11% of the patients presented an additional migraine diagnosis, close value to 56.5% found in a study with Brazilian population 18 . Among the numerous comorbidities of painful, especially chronic conditions, including migraine and TMD, anxiety and depression are prominent due to their high prevalence and their impact 6, 19 . In this study, significant differences were found in the anxiety and depression levels between the groups (p<0.05), and group 2 presented higher averages in both cases (14.87 for anxiety and 12.77 for depression) in relation to group 1 (10.68 for anxiety and 9.79 for depression). This difference can perhaps be explained by the positive correlation between pain intensity and anxiety and depression levels, that is, the more intense the pain (as in cases of concomitant comorbidities), the higher the levels of anxiety and depression 20 . Using the same assessment tools (BAI and BDI), depression anxiety scores in group 2 share the results of Santos, Sandin and Sakae 21 , who found a positive correlation (p=0.031) between anxiety and the headache prevalence in Brazilian university students; and with the results of Falavigna et al. 22 , who found a higher prevalence of depression (p=0.001) in Brazilian adults with headache than in those without headache. Approximately one-third of patients with migraine and anxiety have depression signs; and two-thirds of patients with migraine and depression exhibit anxiety signs, with the anxiety and depression combination associated with a higher headache frequency and anxiety attacks related to headache intensity exacerbation 23 . However, the higher values did not mean, at least in this study, more depression and anxiety. Although statistically different, both groups were included in the mild anxiety score and the mild to moderate depression score. It can be affirmed, therefore, that group 2 presented more intense depression and anxiety symptoms, without this necessarily meaning a worse picture of depression and anxiety. One of the most used instruments to assess headache-related disability is the MIDAS questionnaire 16, 24 . It captures the headache impact over a three months period, considered long enough to represent the actual patient's experience, and short enough to allow a reliable and accurate resumption of headache's history 25 . In this research, there was no study of the results according to gender, or the presence or not of employment for this questionnaire's data, since it is not influenced by these factors 24 . After comparing the MIDAS questionnaire's results, group 2 presented significantly more disability than group 1, in four of the five questions (p<0.05). The only question that did not present significant statistics was No. 5, which measures the lost days in social, family, and leisure activities. This can be explained by the fact that patients tend to lose more days in domestic service (questions 3 and 4) than in leisure, social or family activities (question 5) 26 . In the present study, this fact was verified, with both groups having less lost days, or impaired in question 5 in relation to 3 and 4. Although in this study the average number of days in both groups placed them on the IV score (severe disability) of MIDAS 16 , the patients in group 2 lost or had their production significantly more impaired (56.40 days) in relation to group 1 (35.33 days). Total values of MIDAS are similar to previous ones in the literature, in which TMD and primary headache patients had a total of 49.3 days lost or impaired, whereas patients with only TMD had 23.42 days 27 . These results are expected since, in TMD-patients, disability is significantly increased when associated with primary headache 28 . In addition, patients in group 1 presented higher scores than those in group 2 for grades I (48 and 24.1%, respectively) and II (9.2 and 3.6%, respectively). On the other hand, group 2 presented higher disability scores compared to those in group 1 for grades III (22.9 and 8.2%, respectively) and IV (49.4 and 34.6%, respectively). The distribution in MIDAS grades in group 2 was similar to that found in the study by Di Paolo et al. 29 , in an Italian population evaluating TMD and migraine (I: 28%; II: 8%; III: 8%; IV: 56%), But differs from studies of Corrêa, Santos and Galato 30 (I: 80.6%; II: 9.0%; III: 5.2%; IV: 5.2%) and from Queiroz and Silva Junior 31 (I: 55.4%; II: 18.1%; III: 13.5%; IV: 13%), with Brazilian populations. Possibly, these differences are because Brazilian studies are epidemiological and consider a larger population (not only TMD-patients), and evaluate more than one type of headache (not just migraine). MFP and migraine alone are associated with increased levels of anxiety, depression, and disability, which exacerbate painful conditions 6, 23 . The worsening of these indexes (anxiety, depression, and disability) found in group 2 (coexistence of MFP and migraine comorbidities) suggests that, clinically, the treatments of these conditions should be multiple and also include the psychological/emotional factors to obtain satisfactory results. Future studies may help clarify this issue. All the results of this research should be analyzed with caution, since there are limitations, as it is a cross-sectional, monocentric and restricted population study. It would be interesting to replicate such research, with longitudinal follow-up, in order to better understand the interrelation between comorbidities, as well as to study which patient's characteristics predisposes him or are related to a greater occurrence of the MFP and migraine concomitance.
CONCLUSION
Patients with MFP and migraine presented significantly higher indexes of anxiety, depression and number of days lost and/or impaired, as well as moderate and severe levels of disability considerably higher than the group of patients with only MFP.
